Learn about the effectiveness of tumor-targeted T cell immunotherapy from our patients.

Metastatic breast cancer treatment with DC-CIK immunotherapy

This is a treatment result comparison between two groups of breast cancer patients.

Patients in control group receive chemotherapy only. Patients in comparison group receive chemotherapy and immunotherapy. Read more

Lymph nodes shrank after immunotherapy with dendritic cell and T cell

Mr. Huang from China, a 56 years old lung cancer patient received treatment with dendritic cell and cytotoxic T lymphocytes (CTL, T cell) immunotherapy and gained improvement. Read more

Dendritic cells cancer immunotherapy for melanoma improved immunity index

This is a treatment result comparison between two groups of patients.

The value of CD3+, CD3+CD4+, CD4+/CD8+ and NK (Natural Killer) cells in peripheral blood significantly increased after a combination treatment including dendritic cells immunotherapy (DC therapy), comparing with patients who did not have DC therapy. Read more

Activated T cells increased after iAPA cancer immunotherapy

This comparison report shows that the activated T cells are significantly increased, and the Regulatory T cells significantly declined after the cancer treatment, which means this patient’s immune system can kill more cancer cells in the body. This is a study on a patient with colorectal cancer. Read more

Metastasis removed after DC-CTL cancer immunotherapy

Mr. Chu is a 58 years old Chinese male with diagnosis of colon cancer.

In November 2007, at the outer line of sigmoid colon cancer resection, he was given after four cycles of Eloxatin and Xeloda chemotherapy. In February 2008, Mr. Chu prompted to relapse by colonoscopy, with second surgery at a cancer hospital in Shanghai, after surgery revealed no metastasis, the original course of chemotherapy continued for six weeks. Read more

Cancer immunotherapy declined Mr. Zhao’s PSA

Mr. Zhao, 51 years old male from China. Four years ago, he was diagnosed with prostate cancer with multi-metastasis to bone. His PSA value kept rising up to as high as 940.9. He never had an effective treatment until he received the DC-CTL cancer immunotherapy (dendritic cell and T cell based). During the treatment with immunotherapy, he did not have any other treatment at the same time. Read more

Hope for a young man with lung cancer

Xiao Jian is a 25 years old young man from an ordinary family in Anhui province. In the summer of 2012, symptoms like coughing, fever, chest discomfort or breathing difficulties occasionally happened to him. Xiao Jiang thought they were caused by catching a cold until one day he was hard to breathe after playing a short while in a basketball game. He tried several times, but he could never play for over an hour, which was so easy for him in the past. What was wrong with Xiao Jian? Read more